What the FDA isn’t telling about duloxetine
When researchers and the press started asking about duloxetine, the FDA didn’t scour its database and go public. It kept quiet. More
When researchers and the press started asking about duloxetine, the FDA didn’t scour its database and go public. It kept quiet. More